Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague.
An attenuated Salmonella typhimurium strain which expressed the F1 capsular antigen of Yersinia pestis was constructed by transformation of S. typhimurium SL3261 with plasmid pFGAL2a, a derivative of pUC18 which contained the caf1 gene without the leader sequence. The recombinant was used to vaccinate mice intragastrically and intravenously. The immunity induced was able to protect mice against challenge with a virulent strain of plague. Protection correlated with the induction of high titers of immunoglobulin G in serum samples and a specific T-cell response.
Oyston
P C
PC
Chemical and Biological Defence Establishment, Salisbury, Wiltshire, United Kingdom.
Williamson
E D
ED
Leary
S E
SE
Eley
S M
SM
Griffin
K F
KF
Titball
R W
RW
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology*; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology*; D001483:Base Sequence; D003001:Cloning, Molecular; D017931:DNA Primers / Q000737:chemistry; D005260:Female; D005798:Genes, Bacterial; D007111:Immunity, Cellular; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D010930:Plague / Q000517:prevention & control*; D012486:Salmonella typhimurium; D013154:Spleen / Q000276:immunology; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic / Q000276:immunology; D015010:Yersinia pestis / Q000276:immunology*
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D017931:DNA Primers; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; C086725:caf1 protein, Yersinia pestis